Barclays PLC Cbd Md, Inc. Transaction History

Barclays PLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$0.0 - $6.95 $0 - $76,943	-11,071 Reduced 99.1%	100 $0
Q3 2021 Nov 09, 2021	BUY	$0.0 - $7.49 $0 - $58,459	7,805 Added 231.88%	11,171 $23,000
Q2 2021 Aug 13, 2021	BUY	$7.46 - $9.49 $6,639 - $8,446	890 Added 35.95%	3,366 $10,000
Q1 2021 May 13, 2021	BUY	$7.81 - $10.5 $19,337 - $25,998	2,476 New	2,476 $10,000
Q3 2020 Nov 12, 2020	SELL	$7.61 - $9.0 $65,978 - $78,030	-8,670 Closed	0 $0
Q2 2020 Aug 12, 2020	SELL	$5.32 - $8.54 $4,819 - $7,737	-906 Reduced 9.46%	8,670 $16,000
Q1 2020 May 13, 2020	SELL	$2.85 - $8.09 $2,604 - $7,394	-914 Reduced 8.71%	9,576 $9,000
Q4 2019 Feb 10, 2020	BUY	$7.5 - $175.05 $39,547 - $923,038	5,273 Added 101.07%	10,490 $23,000
Q3 2019 Nov 14, 2019	SELL	$172.8 - $228.6 $183,340 - $242,544	-1,061 Reduced 16.9%	5,217 $21,000
Q2 2019 Aug 14, 2019	BUY	N/A	6,278 New	6,278 $37,000

125K

Ticker YCBD
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 60,555,600
Market Cap $29.1M
Description
cbdMD, Inc. produces and distributes various cannabidiol (CBD) products. The company owns and operates consumer hemp-based CBD brands, such as cbdMD, Paw CBD, and cbdMD Botanicals. Its cbdMD brand products include CDB tinctures, gummies, topicals, capsules, bath bombs, bath salts, and sleep aids. It also offers veterinarian-formulated products, ...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.